The worldwide Automated Breast Ultrasound System (ABUS) Market has a high market size in 2020, and it is predicted to grow rapidly over the forecast period. According to industry analysis, the increasing prevalence of breast cancer as a result of hormone replacement therapy, obesity, rising preference to not bear children, and age-related conditions and diseases are driving demand for Automated Breast Ultrasound System (ABUS) deployment and subsequent patient screening. Because of the rising frequency of breast cancer, an increasing number of centers are using ABUS, since this technology is a prospective rival to mammography in the future.
An automated breast ultrasound system is specially developed to make ultrasound pictures by scanning over the breast with a broadband transducer to gather 3D ultrasound volume data. ABUS generates three-dimensional pictures and detects cancer in thick breast tissue. Among the benefits of ABUS include improved diagnostic accuracy of breast lesions in terms of early diagnosis, better classification, and more accurate evaluation. ABUS is operator-independent and uses less energy for screening and results, and full-body breast scanning may be performed with no ionizing radiation and no contraindications. Ultrasound in breast scan creates a black-and-white picture of tissues and structures in the breast using high-frequency sound waves. Doctors frequently use this test to analyze the size and form of lumps in the breast and determine if they are tumorous growths or fluid-filled cysts. Women with thick breasts are more likely to develop breast cancer, and ABUS is successful in finding mammographically occult cancer in women with dense tissue, whereas mammography has a lower sensitivity. Diagnostic radiologists can see what mammography cannot, and combining ultrasound with a mammogram aids in detection at any age, but notably in the case of women with very thick breasts. Furthermore, symptomatic women 45 years or younger are advised to get breast ultrasonography since it is more accurate than mammography. Mammography, on the other hand, has shown a gradual increase in sensitivity in women aged 60 and up.
The market for automated breast ultrasound systems (ABUS) has been divided into product and application segments, which include hospitals and research laboratories, as well as diagnostics imaging laboratories. Automated breast ultrasound technologies save scanning time and reduce reliance on the operator. It also enhances the repeatability, accuracy, dependability, and sensitivity of each individual's full breast ultrasound diagnostic.